Skip Content
You are currently on the new version of our website. Access the old version .

Cancers, Volume 14, Issue 1

2022 January-1 - 262 articles

Cover Story: The management of prostate cancer has improved over the last 20 years; despite this, advanced disease remains invariably fatal. Evasion of apoptosis is a hallmark of cancer, and thus, triggering apoptotic cancer cell death is an attractive therapeutic strategy. Targeting the intrinsic apoptosis pathway with BH3 mimetics has been successful for hematological malignancies. Utilizing these agents for solid malignancies has been more challenging, though efforts are ongoing. Molecular characterization and the development of predictive biomarkers is likely to be critical for patient selection. Here, we provide an up-to-date overview of cell death, specifically focusing on the intrinsic apoptosis pathway. We summarize the latest approaches for targeting the intrinsic apoptosis pathway with BH3 mimetics and discuss how these strategies may be leveraged to treat prostate cancer. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (262)

  • Article
  • Open Access
9 Citations
7,163 Views
15 Pages

Reliability of Alkaline Phosphatase for Differentiating Flare Phenomenon from Disease Progression with Bone Scintigraphy

  • Ji-hoon Jung,
  • Chae-Moon Hong,
  • Il Jo,
  • Shin-Young Jeong,
  • Sang-Woo Lee,
  • Jaetae Lee and
  • Byeong-Cheol Ahn

5 January 2022

The flare phenomenon (FP) on bone scintigraphy after the initiation of systemic treatment seriously complicates evaluations of therapeutic response in patients with bone metastases. The aim of this study was to evaluate whether serum alkaline phospha...

  • Article
  • Open Access
15 Citations
3,942 Views
16 Pages

RhoGDI2-Mediated Rac1 Recruitment to Filamin A Enhances Rac1 Activity and Promotes Invasive Abilities of Gastric Cancer Cells

  • Hyo-Jin Kim,
  • Ki-Jun Ryu,
  • Minju Kim,
  • Taeyoung Kim,
  • Seon-Hee Kim,
  • Hyeontak Han,
  • Hyemin Kim,
  • Keun-Seok Hong,
  • Chae Yeong Song and
  • Jiyun Yoo
  • + 3 authors

5 January 2022

Rho GDP dissociation inhibitor 2 (RhoGDI2), a regulator of Rho family GTPase, has been known to promote tumor growth and malignant progression in gastric cancer. We previously showed that RhoGDI2 positively regulates Rac1 activity and Rac1 activation...

  • Article
  • Open Access
7 Citations
4,800 Views
19 Pages

5 January 2022

Chronic myeloid leukemia (CML) is a slowly progressing blood cancer that primarily affects elderly people. Without successful treatment, CML progressively develops from the chronic phase through the accelerated phase to the blast crisis, and ultimate...

  • Review
  • Open Access
4 Citations
4,933 Views
23 Pages

Neuropsychiatric Disorders and Frailty in Older Adults over the Spectrum of Cancer: A Narrative Review

  • Mariya Muzyka,
  • Luca Tagliafico,
  • Gianluca Serafini,
  • Ilaria Baiardini,
  • Fulvio Braido,
  • Alessio Nencioni and
  • Fiammetta Monacelli

5 January 2022

Background: The interplay between different neuropsychiatric conditions, beyond dementia, in the presence of a diagnosis of cancer in older adults may mediate patients’ fitness and cancer-related outcomes. Here, we aimed to investigate the pres...

  • Review
  • Open Access
50 Citations
10,405 Views
26 Pages

Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy

  • Myriam Ben Khelil,
  • Yann Godet,
  • Syrine Abdeljaoued,
  • Christophe Borg,
  • Olivier Adotévi and
  • Romain Loyon

5 January 2022

Over the past decades, CD4+ T cells have been considered as a supporting actor in the fields of cancer immunotherapy. Until recently, accumulating evidence has demonstrated the critical role of CD4+ T cells during antitumor immunity. CD4+ T cells can...

  • Article
  • Open Access
13 Citations
4,324 Views
17 Pages

Lysyl-Oxidase Dependent Extracellular Matrix Stiffness in Hodgkin Lymphomas: Mechanical and Topographical Evidence

  • Massimo Alfano,
  • Irene Locatelli,
  • Cristina D’Arrigo,
  • Marco Mora,
  • Giovanni Vozzi,
  • Aurora De Acutis,
  • Roberta Pece,
  • Sara Tavella,
  • Delfina Costa and
  • Maria Raffaella Zocchi
  • + 1 author

5 January 2022

Purpose: The biochemical composition and architecture of the extracellular matrix (ECM) is known to condition development and invasiveness of neoplasms. To clarify this point, we analyzed ECM stiffness, collagen cross-linking and anisotropy in lymph...

  • Article
  • Open Access
15 Citations
4,929 Views
14 Pages

Blood-Derived Extracellular Vesicle-Associated miR-3182 Detects Non-Small Cell Lung Cancer Patients

  • Kekoolani S. Visan,
  • Richard J. Lobb,
  • Shu Wen Wen,
  • Justin Bedo,
  • Luize G. Lima,
  • Sophie Krumeich,
  • Carlos Palma,
  • Kaltin Ferguson,
  • Ben Green and
  • Andreas Möller
  • + 10 authors

5 January 2022

With five-year survival rates as low as 3%, lung cancer is the most common cause of cancer-related mortality worldwide. The severity of the disease at presentation is accredited to the lack of early detection capacities, resulting in the reliance on...

  • Article
  • Open Access
18 Citations
4,644 Views
12 Pages

Association between CT-Based Preoperative Sarcopenia and Outcomes in Patients That Underwent Liver Resections

  • David Martin,
  • Yaël Maeder,
  • Kosuke Kobayashi,
  • Michael Schneider,
  • Joachim Koerfer,
  • Emmanuel Melloul,
  • Nermin Halkic,
  • Martin Hübner,
  • Nicolas Demartines and
  • Emilie Uldry
  • + 1 author

5 January 2022

This retrospective observational study aimed to evaluate whether preoperative sarcopenia, assessed by CT imaging, was associated with postoperative clinical outcomes and overall survival in patients that underwent liver resections. Patients operated...

  • Article
  • Open Access
8 Citations
4,952 Views
22 Pages

5 January 2022

Current anticancer treatments are inefficient against glioblastoma multiforme (GBM), which remains one of the most aggressive and lethal cancers. Evidence has shown the presence of glioblastoma stem cells (GSCs), which are chemoradioresistant and ass...

  • Article
  • Open Access
48 Citations
7,392 Views
17 Pages

Upregulation of CD36, a Fatty Acid Translocase, Promotes Colorectal Cancer Metastasis by Increasing MMP28 and Decreasing E-Cadherin Expression

  • James Drury,
  • Piotr G. Rychahou,
  • Courtney O. Kelson,
  • Mariah E. Geisen,
  • Yuanyuan Wu,
  • Daheng He,
  • Chi Wang,
  • Eun Y. Lee,
  • B. Mark Evers and
  • Yekaterina Y. Zaytseva

5 January 2022

Altered fatty acid metabolism continues to be an attractive target for therapeutic intervention in cancer. We previously found that colorectal cancer (CRC) cells with a higher metastatic potential express a higher level of fatty acid translocase (CD3...

  • Article
  • Open Access
2 Citations
3,725 Views
19 Pages

The Molecular Landscape of Medulloblastoma in Teenagers and Young Adults

  • Omar J. Mohammed,
  • Maria Estevez Cebrero,
  • Omar Ahmad,
  • Andrew Peet,
  • Richard G. Grundy and
  • Anbarasu Lourdusamy

5 January 2022

Medulloblastoma (MB) is a childhood malignant brain tumour but also occurs in teenagers and young adults (TYA). Considering that MB is heterogeneous, this study aimed to define the molecular landscape of MBs in TYAs. We collated more than 2000 MB sam...

  • Article
  • Open Access
5 Citations
3,552 Views
12 Pages

5 January 2022

Background: Risk of metastatic recurrence of breast cancer after initial diagnosis and treatment depends on the presence of a number of risk factors. Although most univariate risk factors have been identified using classical methods, machine-learning...

  • Article
  • Open Access
18 Citations
3,263 Views
13 Pages

Genetic Analysis Reveals the Prognostic Significance of the DNA Mismatch Repair Gene MSH2 in Advanced Prostate Cancer

  • Hao-Han Chang,
  • Cheng-Hsueh Lee,
  • Yei-Tsung Chen,
  • Chao-Yuan Huang,
  • Chia-Cheng Yu,
  • Victor C. Lin,
  • Jiun-Hung Geng,
  • Te-Ling Lu,
  • Shu-Pin Huang and
  • Bo-Ying Bao

4 January 2022

DNA damage repair is frequently dysregulated in advanced prostate cancer and has been linked to cancer susceptibility and survival outcomes. The aim of this study is to assess the influence of genetic variants in DNA damage repair pathways on the pro...

  • Article
  • Open Access
3 Citations
2,736 Views
10 Pages

Utility of 3T MRI in Women with IB1 Cervical Cancer in Determining the Necessity of Less Invasive Surgery

  • Soo Young Jeong,
  • Byung Kwan Park,
  • Chel Hun Choi,
  • Yoo-Young Lee,
  • Tae-Joong Kim,
  • Jeong-Won Lee and
  • Byoungi-Gie Kim

4 January 2022

Purpose: Cervical cancer that is invisible on magnetic resonance imaging (MRI) may suggest lower tumor burden than physical examination. Recently, 3 tesla (3T) MRI has been widely used prior to surgery because of its higher resolution than 1.5T MRI....

  • Article
  • Open Access
22 Citations
4,453 Views
10 Pages

Post-Irradiation Sinus Mucosa Disease in Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Proton Therapy

  • Pei-Wen Wu,
  • Chien-Chia Huang,
  • Yun-Shien Lee,
  • Yung-Chih Chou,
  • Kang-Hsing Fan,
  • Chien-Yu Lin,
  • Bing-Shen Huang,
  • Shih-Wei Yang,
  • Chi-Che Huang and
  • Joseph Tung-Chieh Chang
  • + 2 authors

4 January 2022

In the past decade, patients with nasopharyngeal cancer (NPC) have been deemed candidates for proton radiotherapy, due to the large and comprehensive target volumes and the necessity for the retention of the surrounding healthy tissues. In this study...

  • Review
  • Open Access
101 Citations
8,732 Views
22 Pages

Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy

  • Konstantinos Arvanitakis,
  • Triantafyllia Koletsa,
  • Ioannis Mitroulis and
  • Georgios Germanidis

4 January 2022

Hepatocellular carcinoma (HCC) constitutes a major health burden globally, and it is caused by intrinsic genetic mutations acting in concert with a multitude of epigenetic and extrinsic risk factors. Cancer induces myelopoiesis in the bone marrow, as...

  • Review
  • Open Access
23 Citations
5,498 Views
13 Pages

Implication of Ceramide Kinase/C1P in Cancer Development and Progression

  • Laura Camacho,
  • Alberto Ouro,
  • Ana Gomez-Larrauri,
  • Arkaitz Carracedo and
  • Antonio Gomez-Muñoz

4 January 2022

Cancer cells rewire their metabolic programs to favor biological processes that promote cell survival, proliferation, and dissemination. Among this relevant reprogramming, sphingolipid metabolism provides metabolites that can favor or oppose these ha...

  • Article
  • Open Access
26 Citations
4,790 Views
18 Pages

Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study

  • Ramya Ambur Sankaranarayanan,
  • Jennifer Peil,
  • Andreas T. J. Vogg,
  • Carsten Bolm,
  • Steven Terhorst,
  • Arno Classen,
  • Matthias Bauwens,
  • Jochen Maurer,
  • Felix Mottaghy and
  • Agnieszka Morgenroth

4 January 2022

PARP1 inhibitors (PARPi) are currently approved for BRCAmut metastatic breast cancer, but they have shown limited response in triple negative breast cancer (TNBC) patients. Combination of an Auger emitter with PARPis enables PARP inhibition and DNA s...

  • Article
  • Open Access
10 Citations
3,313 Views
17 Pages

Metabolic Reprogramming and Risk Stratification of Hepatocellular Carcinoma Studied by Using Gas Chromatography–Mass Spectrometry-Based Metabolomics

  • Chengnan Fang,
  • Hui Wang,
  • Zhikun Lin,
  • Xinyu Liu,
  • Liwei Dong,
  • Tianyi Jiang,
  • Yexiong Tan,
  • Zhen Ning,
  • Yaorui Ye and
  • Guowang Xu
  • + 1 author

4 January 2022

Hepatocellular carcinoma (HCC) displays a high degree of metabolic and phenotypic heterogeneity and has dismal prognosis in most patients. Here, a gas chromatography–mass spectrometry (GC-MS)-based nontargeted metabolomics method was applied to...

  • Review
  • Open Access
28 Citations
6,186 Views
16 Pages

Lipid Metabolism in Cancer: The Role of Acylglycerolphosphate Acyltransferases (AGPATs)

  • Angeliki Karagiota,
  • Georgia Chachami and
  • Efrosyni Paraskeva

4 January 2022

Altered lipid metabolism is an emerging hallmark of aggressive tumors, as rapidly proliferating cancer cells reprogram fatty acid (FA) uptake, synthesis, storage, and usage to meet their increased energy demands. Central to these adaptive changes, is...

  • Review
  • Open Access
11 Citations
6,030 Views
18 Pages

Secretory Autophagy Forges a Therapy Resistant Microenvironment in Melanoma

  • Silvina Odete Bustos,
  • Nathalia Leal Santos,
  • Roger Chammas and
  • Luciana Nogueira de Sousa Andrade

4 January 2022

Melanoma is the most aggressive skin cancer characterized by high mutational burden and large heterogeneity. Cancer cells are surrounded by a complex environment, critical to tumor establishment and progression. Thus, tumor-associated stromal compone...

  • Article
  • Open Access
28 Citations
3,959 Views
13 Pages

Circulating Cell-Free DNA-Based Comprehensive Molecular Analysis of Biliary Tract Cancers Using Next-Generation Sequencing

  • Szilvia Lilla Csoma,
  • Judit Bedekovics,
  • Gergő Veres,
  • Anita Árokszállási,
  • Csilla András,
  • Gábor Méhes and
  • Attila Mokánszki

4 January 2022

Biliary tract cancer (BTC) is a rare malignancy with a long disease course and an overall poor prognosis. Despite multiple chemotherapy agents, there is no defined second-line treatment opportunity for advanced BTCs. In the era of precision oncology,...

  • Article
  • Open Access
5 Citations
3,403 Views
15 Pages

4 January 2022

Radionuclide treatment of patients with neuroendocrine tumors has advanced in the last decades with favorable results using 177Lu-octreotate. However, the gap between the high cure rate in animal studies vs. patient studies indicates a potential to i...

  • Article
  • Open Access
10 Citations
2,638 Views
14 Pages

Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma

  • Zijian Yang,
  • Goki Suda,
  • Osamu Maehara,
  • Masatsugu Ohara,
  • Sonoe Yoshida,
  • Shunichi Hosoda,
  • Megumi Kimura,
  • Akinori Kubo,
  • Yoshimasa Tokuchi and
  • Naoya Sakamoto
  • + 11 authors

4 January 2022

Serum growth factor changes and their effect on prognosis during lenvatinib for unresectable hepatocellular carcinoma (HCC) remain underexplored. The sequential changes in serum growth factors during lenvatinib for unresectable HCC were evaluated in...

  • Review
  • Open Access
16 Citations
4,196 Views
20 Pages

Contribution of LAT1-4F2hc in Urological Cancers via Toll-like Receptor and Other Vital Pathways

  • Xue Zhao,
  • Shinichi Sakamoto,
  • Maihulan Maimaiti,
  • Naohiko Anzai and
  • Tomohiko Ichikawa

4 January 2022

Tumor cells are known for their ability to proliferate. Nutrients are essential for rapidly growing tumor cells. In particular, essential amino acids are essential for tumor cell growth. Tumor cell growth nutrition requires the regulation of membrane...

  • Article
  • Open Access
9 Citations
4,627 Views
21 Pages

Comprehensive Pan-Cancer Analyses of Pyroptosis-Related Genes to Predict Survival and Immunotherapeutic Outcome

  • Qilin Wang,
  • Qian Liu,
  • Sihan Qi,
  • Junyou Zhang,
  • Xian Liu,
  • Xin Li and
  • Chunyan Li

4 January 2022

Pyroptosis is a newly characterized type of programmed cell death. However, its function in cancer progression and its response to treatments remain controversial. Here, we extensively and systematically compiled genes associated with pyroptosis, int...

  • Review
  • Open Access
181 Citations
14,860 Views
28 Pages

4 January 2022

The extracellular matrix (ECM) is highly dynamic as it is constantly deposited, remodeled and degraded to maintain tissue homeostasis. ECM is a major structural component of the tumor microenvironment, and cancer development and progression require i...

  • Review
  • Open Access
40 Citations
5,283 Views
14 Pages

4 January 2022

Approximately 20% of patients with renal cell carcinoma (RCC) present with primarily metastatic disease and over 30% of patients with localized RCC will develop distant metastases later, after complete resection of the primary tumor. Accurate postope...

  • Article
  • Open Access
12 Citations
3,648 Views
11 Pages

BRCA 1/2 Germline Mutation Predicts the Treatment Response of FOLFIRINOX with Pancreatic Ductal Adenocarcinoma in Korean Patients

  • Ji Hoon Park,
  • Jung Hyun Jo,
  • Sung Ill Jang,
  • Moon Jae Chung,
  • Jeong Youp Park,
  • Seungmin Bang,
  • Seung Woo Park,
  • Si Young Song,
  • Hee Seung Lee and
  • Jae Hee Cho

4 January 2022

We evaluated the proportion of BRCA 1/2 germline mutations in Korean patients with sporadic pancreatic ductal adenocarcinoma (PDAC) and its effect on the chemotherapeutic response of FOLFIRINOX. This retrospective study included patients who were tre...

  • Article
  • Open Access
7 Citations
3,404 Views
10 Pages

A New Approach for a Safe and Reproducible Seeds Positioning for Diffusing Alpha-Emitters Radiation Therapy of Squamous Cell Skin Cancer: A Feasibility Study

  • Giacomo Feliciani,
  • Salvatore Roberto Bellia,
  • Massimo Del Duca,
  • Giorgio Mazzotti,
  • Manuela Monti,
  • Ignazio Stanganelli,
  • Yona Keisari,
  • Itzhak Kelson,
  • Aron Popovtzer and
  • Anna Sarnelli
  • + 1 author

4 January 2022

The purpose of this study is to discuss how to use an external radio-opaque template in the Diffusing Alpha-emitters Radiation Therapy (DaRT) technique’s pre-planning and treatment stages. This device would help to determine the proper number o...

  • Article
  • Open Access
39 Citations
7,680 Views
13 Pages

Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver Metastases

  • Valentina Giannini,
  • Laura Pusceddu,
  • Arianna Defeudis,
  • Giulia Nicoletti,
  • Giovanni Cappello,
  • Simone Mazzetti,
  • Andrea Sartore-Bianchi,
  • Salvatore Siena,
  • Angelo Vanzulli and
  • Daniele Regge
  • + 5 authors

4 January 2022

The purpose of this paper is to develop and validate a delta-radiomics score to predict the response of individual colorectal cancer liver metastases (lmCRC) to first-line FOLFOX chemotherapy. Three hundred one lmCRC were manually segmented on both C...

  • Review
  • Open Access
26 Citations
5,677 Views
12 Pages

Recent Advances in the Diagnosis and Management of Multiple Primary Lung Cancer

  • Chi-Lu Chiang,
  • Ping-Chung Tsai,
  • Yi-Chen Yeh,
  • Yuan-Hung Wu,
  • Han-Shui Hsu and
  • Yuh-Min Chen

4 January 2022

With the wide application of computed tomography in lung cancer screening, the incidence of multiple primary lung cancer (MPLC) has been increasingly reported. Despite the established criteria, the differentiation between MPLC and intrapulmonary meta...

  • Review
  • Open Access
29 Citations
7,603 Views
16 Pages

Glutamine-Derived Aspartate Biosynthesis in Cancer Cells: Role of Mitochondrial Transporters and New Therapeutic Perspectives

  • Ruggiero Gorgoglione,
  • Valeria Impedovo,
  • Christopher L. Riley,
  • Deborah Fratantonio,
  • Stefano Tiziani,
  • Luigi Palmieri,
  • Vincenza Dolce and
  • Giuseppe Fiermonte

4 January 2022

Aspartate has a central role in cancer cell metabolism. Aspartate cytosolic availability is crucial for protein and nucleotide biosynthesis as well as for redox homeostasis. Since tumor cells display poor aspartate uptake from the external environmen...

  • Article
  • Open Access
8 Citations
4,237 Views
14 Pages

Predicting Frailty and Geriatric Interventions in Older Cancer Patients: Performance of Two Screening Tools for Seven Frailty Definitions—ELCAPA Cohort

  • Claudia Martinez-Tapia,
  • Marie Laurent,
  • Elena Paillaud,
  • Philippe Caillet,
  • Emilie Ferrat,
  • Jean-Léon Lagrange,
  • Jean-Paul Rwabihama,
  • Mylène Allain,
  • Anne Chahwakilian and
  • Etienne Audureau
  • + 2 authors

4 January 2022

Screening tools have been developed to identify patients warranting a complete geriatric assessment (GA). However, GA lacks standardization and does not capture important aspects of geriatric oncology practice. We measured and compared the diagnostic...

  • Article
  • Open Access
18 Citations
4,411 Views
18 Pages

Comparative O-GlcNAc Proteomic Analysis Reveals a Role of O-GlcNAcylated SAM68 in Lung Cancer Aggressiveness

  • Chia-Hung Lin,
  • Chen-Chung Liao,
  • Shu-Ying Wang,
  • Chia-Yi Peng,
  • Yi-Chen Yeh,
  • Mei-Yu Chen and
  • Teh-Ying Chou

4 January 2022

O-GlcNAcylation is a reversible and dynamic post-translational protein modification catalyzed by O-GlcNAc transferase (OGT). Despite the reported association of O-GlcNAcylation with cancer metastasis, the O-GlcNAc proteome profile for cancer aggressi...

  • Article
  • Open Access
6 Citations
3,579 Views
13 Pages

Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling

  • Bent Honoré,
  • Maja Dam Andersen,
  • Diani Wilken,
  • Peter Kamper,
  • Francesco d’Amore,
  • Stephen Hamilton-Dutoit and
  • Maja Ludvigsen

4 January 2022

In classic Hodgkin lymphoma (cHL), the tumour microenvironment (TME) is of major pathological relevance. The paucity of neoplastic cells makes it important to study the entire TME when searching for prognostic biomarkers. Cure rates in cHL have impro...

  • Article
  • Open Access
11 Citations
4,730 Views
22 Pages

Epigenetic Priming with Decitabine Augments the Therapeutic Effect of Cisplatin on Triple-Negative Breast Cancer Cells through Induction of Proapoptotic Factor NOXA

  • Wataru Nakajima,
  • Kai Miyazaki,
  • Masahiro Sakaguchi,
  • Yumi Asano,
  • Mariko Ishibashi,
  • Tomoko Kurita,
  • Hiroki Yamaguchi,
  • Hiroyuki Takei and
  • Nobuyuki Tanaka

4 January 2022

Epigenetic alterations caused by aberrant DNA methylation have a crucial role in cancer development, and the DNA-demethylating agent decitabine, is used to treat hematopoietic malignancy. Triple-negative breast cancers (TNBCs) have shown sensitivity...

  • Article
  • Open Access
10 Citations
3,331 Views
11 Pages

Cause of Death, Mortality and Occult Blood in Colorectal Cancer Screening

  • Lasse Kaalby,
  • Issam Al-Najami,
  • Ulrik Deding,
  • Gabriele Berg-Beckhoff,
  • Robert J. C. Steele,
  • Morten Kobaek-Larsen,
  • Aasma Shaukat,
  • Morten Rasmussen and
  • Gunnar Baatrup

4 January 2022

Fecal hemoglobin (f-Hb) detected by the guaiac fecal occult blood test (gFOBT) may be associated with mortality and cause of death in colorectal cancer (CRC) screening participants. We investigated this association in a randomly selected population o...

  • Review
  • Open Access
6 Citations
3,721 Views
12 Pages

Paraneoplastic Syndromes in Patients with Keratinocyte Skin Cancer

  • Christoforos Vlachos,
  • Chrysanthi Tziortzioti and
  • Ioannis D. Bassukas

4 January 2022

A variety of well-characterized cutaneous paraneoplastic syndromes (PNS) are diagnosed during internal malignancies; however, the spectrum of keratinocyte skin neoplasms (KSC) related to PNS is still obscure. The aim of the present review is to compi...

  • Review
  • Open Access
31 Citations
6,111 Views
14 Pages

4 January 2022

The tumor microenvironment (TME) comprises various cell types, soluble factors, viz, metabolites or cytokines, which together play in promoting tumor metastasis. Tumor infiltrating immune cells play an important role against cancer, and metabolic swi...

  • Article
  • Open Access
19 Citations
3,705 Views
16 Pages

Early Response Prediction of Multiparametric Functional MRI and 18F-FDG-PET in Patients with Head and Neck Squamous Cell Carcinoma Treated with (Chemo)Radiation

  • Roland M. Martens,
  • Thomas Koopman,
  • Cristina Lavini,
  • Tim van de Brug,
  • Gerben J. C. Zwezerijnen,
  • J. Tim Marcus,
  • Marije R. Vergeer,
  • C. René Leemans,
  • Remco de Bree and
  • Jonas A. Castelijns
  • + 2 authors

3 January 2022

Background: Patients with locally-advanced head and neck squamous cell carcinoma (HNSCC) have variable responses to (chemo)radiotherapy. A reliable prediction of outcomes allows for enhancing treatment efficacy and follow-up monitoring. Methods: Fift...

  • Review
  • Open Access
39 Citations
5,586 Views
16 Pages

3 January 2022

Pancreatic ductal adenocarcinoma (PDAC) is still difficult to treat due to insufficient methods for early diagnosis and prediction of therapy response. Furthermore, surveillance after curatively intended surgery lacks adequate methods for timely dete...

  • Article
  • Open Access
20 Citations
3,500 Views
14 Pages

Microsatellite Instability, Epstein–Barr Virus, and Programmed Cell Death Ligand 1 as Predictive Markers for Immunotherapy in Gastric Cancer

  • Hung-Yuan Yu,
  • Chung-Pin Li,
  • Yi-Hsiang Huang,
  • Shao-Jung Hsu,
  • Yen-Po Wang,
  • Yun-Cheng Hsieh,
  • Wen-Liang Fang,
  • Kuo-Hung Huang,
  • Anna Fen-Yau Li and
  • Yee Chao
  • + 9 authors

3 January 2022

Immunotherapy benefits selected cases of gastric cancer (GC), but the correlation between biomarkers and prognosis is still unclear. Fifty-two patients with GC who underwent immunotherapy were enrolled from June 2016 to December 2020. Their clinical...

  • Review
  • Open Access
9 Citations
5,781 Views
16 Pages

3 January 2022

The role played by the key tumor suppressor gene p53 and the implications of p53 mutations for the development and progression of neoplasia continue to expand. This review focuses on colorectal cancer and the regulators of p53 expression and activity...

  • Article
  • Open Access
2 Citations
2,300 Views
16 Pages

3 January 2022

(1) Background: Pretreatment by Rad51-inhibitory substances such as gemcitabine followed by arterial chemotherapy using antineoplastic agents causing DNA crosslink might be more beneficial for patients with locally advanced pancreatic cancers than co...

  • Article
  • Open Access
37 Citations
4,257 Views
10 Pages

High Plus Low Dose Radiation Strategy in Combination with TIGIT and PD1 Blockade to Promote Systemic Antitumor Responses

  • Hampartsoum B. Barsoumian,
  • Duygu Sezen,
  • Hari Menon,
  • Ahmed I. Younes,
  • Yun Hu,
  • Kewen He,
  • Nahum Puebla-Osorio,
  • Mark Wasley,
  • Ethan Hsu and
  • James W. Welsh
  • + 3 authors

3 January 2022

Tumors deploy various immune-evasion mechanisms that create a suppressive environment and render effector T-cells exhausted and inactive. Therefore, a rational utilization of checkpoint inhibitors may alleviate exhaustion and may partially restore an...

  • Review
  • Open Access
11 Citations
7,055 Views
16 Pages

3 January 2022

Brachytherapy (BT) involves the direct application of radioactive sources to the tumour. This technique is characterised by a steep dose gradient, the delivery of high-dose radiation to the target volume centre, and the sparing of surrounding healthy...

  • Article
  • Open Access
24 Citations
4,917 Views
15 Pages

Phototheranostics of Cervical Neoplasms with Chlorin e6 Photosensitizer

  • Aida Gilyadova,
  • Anton Ishchenko,
  • Artem Shiryaev,
  • Polina Alekseeva,
  • Kanamat Efendiev,
  • Radmila Karpova,
  • Maxim Loshchenov,
  • Victor Loschenov and
  • Igor Reshetov

2 January 2022

(1) Purpose: Improving the treatment effectiveness of intraepithelial neoplasia of the cervix associated with human papillomavirus infection, based on the application of the method of photodynamic therapy with simultaneous laser excitation of fluores...

  • Article
  • Open Access
19 Citations
5,252 Views
15 Pages

Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study

  • Matteo Tantari,
  • Stefano Bogliolo,
  • Matteo Morotti,
  • Vincent Balaya,
  • Florent Bouttitie,
  • Annie Buenerd,
  • Laurent Magaud,
  • Fabrice Lecuru,
  • Benedetta Guani and
  • on behalf of the SENTICOL Group
  • + 1 author

2 January 2022

Background: In patients with cervical cancer, the presence of tumoral lymph-vascular space invasion (LVSI) is the main risk factor for pelvic lymph node metastasis (PLNM). The objective of this study was to evaluate the presence of several markers of...

  • Review
  • Open Access
2 Citations
4,948 Views
20 Pages

2 January 2022

Since 2019, the SARS-CoV-2 pandemic has caused a huge chaos throughout the world and the major threat has been possessed by the immune-compromised individuals involving the cancer patients; their weakened immune response makes them vulnerable and sus...

of 6

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694